Long-term results of super-selective trans-catheter embolization of the vesical arteries for the treatment of intractable bladder haematuria

Tsitskari, Maria; Spiliopoulos, Stavros; Konstantos, Chrysostomos; Palialexis, Konstantinos; Reppas, Lazaros; Brountzos, Elias

doi:10.1186/s42155-020-00188-1

CVIR Endovascular

Table 1 Patients demographics and procedural details

From: Long-term results of super-selective trans-catheter embolization of the vesical arteries for the treatment of intractable bladder haematuria

No Age (yrs)/Sex	DSA findings	Medical history/clinical status	Artery embolized	Embolic Agent	Technical Success	Complications	Re-interventions	Clinical success
1 78 yrs./M	Rt Active extravasation	Ca bladder, HTC drop, HS	Rt Superior vesical	Glue	Yes	No	No	Yes
2 82 yrs./M	Pathologic vascularity	Ca bladder, HTC drop, HS	Bilateral vesical	Particles 300–500 μm	Yes	No	No	Yes
3 58/M	Hypervascular mass	Metastatic osteosarcoma, HS	Rt anterior division of IIA	Gelfoam	Yes	No	No	Yes
4 62/F	Pathologic vascularity	Irradiation cystitis, HS	Bilateral vesical	Particles 300–500 μm 100–300 μm	Yes	No	No	Yes
5 68/M	Pathologic vascularity	CA bladder, HTC drop, UNS	Bilateral vesical	Glue +distal coil Rt IIA	Yes	No	Same day Bilateral super-selective PVA 300-500 μm	Yes
6 73/F	Pathologic vascularity	Ca bladder, HTC drop, HS	Bilateral vesical	Glue	Yes	YES	No	Yes
7 61/M	Pathologic vascularity	Ca bladder, HTC drop, HS	Lt vesical	Particles 250 μm	Yes	No	No	Yes
8 80/F	Pathologic vascularity	Ca bladder, HTC drop, HS	Bilateral vesical	Particles 500–700 μm	Yes	No	No	Yes
9 67/M	Pathologic vascularity	Ca bladder, HTC drop, HS	Bilateral vesical	Glue	Yes	No	No	Yes
10 69/F	Pathologic vascularity	Irradiation cystitis, HTC drop, HS	Rt vesical	Glue + Particles 300–500 μm	Yes	No	Recurrence at 35 days. Rt vesical microspheres 300–500 μm	Yes
11 70/M	Pathologic vascularity	Ca bladder, HTC drop, HS	Rt anterior division of IIA	Gelfoam	Yes	No	Recurrence at 43 days. Conservative treatment	Yes
12 74/F	Hypervascular mass	Ca bladder, HTC drop, HS	Rt vesical	Particles 300–500 μm	Yes	No	No	Yes
13 65/M	Hypervascular mass	Ca bladder, HTC drop, HS	Bilateral vesical	Particles 500 μm	Yes	No	No	Yes
14 78/F	Pathologic vascularity	Ca bladder, HTC drop, HS	Bilateral vesical	Particles 600 μm	Yes	No	No	Yes
15 75/M	Pathologic vascularity	Ca bladder, Previous surgery, HTC drop, HS	No IIA catheterization	N/A	No	No	N/A	No
16 70/F	Pathologic vascularity	Ca bladder, HTC drop, HS	Bilateral vesical	Glue	Yes	No	No	Yes
17 67/M	Lt active extravasation	Ca bladder, HTC drop, UNS	IIA Posterior division	Coil + particles 40 μm	Yes	Ischemia, MI, death	No	No
18 81/M	Pathologic vascularity	Ca bladder, HTC drop, UNS	Bilateral vesical	Particles 300–500 μm	Yes	PES	No	Yes
19 89/M	Pathologic vascularity	Ca bladder, HTC drop, HS	Lt vesical	Glue	Yes	No	No	Yes
20 82/F	Pathologic vascularity	Ca bladder, HTC drop, HS	No IIA catheterization	N/A	No	N/A	N/A	No

Ca cancer, HTC haematocrit, HS haemodynamically stable, UNS haemodynamically unstable, IIA internal iliac artery, MI myocardial infarction, PES post-embolization syndrome

Back to article page